Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response : Lessons from COVID-19.

Format:

Book

Author/Creator:

Medicine, National Academy of.

Committee on Vaccine Research and Development Recommendations for Advancing Pandemic and Seasonal Influenza Preparedness and Response, author.

Contributor:

National Academies of Sciences, Engineering, and Medicine.

Division, Health and Medicine.

Health, Board on Global.

Soltani, Hoda.

Subbarao, Kanta.

Bond, Enriqueta.

National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Vaccine Research and Development Recommendations for Advancing Pandemic and Seasonal Influenza Preparedness and Response.

National Research Council (U.S.). Transportation Research Board.

National Cooperative Highway Research Program.

Series:

NCHRP report,

Language:

English

Subjects (All):

COVID-19 (Disease).

Influenza vaccines.

Physical Description:

1 online resource (179 pages)

Edition:

1st ed.

Place of Publication:

Washington, D.C. : National Academies Press, 2022.

Summary:

The global response to COVID-19 has demonstrated the importance of vigilance and preparedness for infectious diseases, particularly influenza. There is a need for more effective influenza vaccines and modern manufacturing technologies that are adaptable and scalable to meet demand during a pandemic. The rapid development of COVID-19 vaccines has demonstrated what is possible with extensive data sharing, researchers who have the necessary resources and novel technologies to conduct and apply their research, rolling review by regulators, and public-private partnerships. As demonstrated throughout the response to COVID-19, the process of research and development of novel vaccines can be significantly optimized when stakeholders are provided with the resources and technologies needed to support their response.Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response focuses on how to leverage the knowledge gained from the COVID-19 pandemic to optimize vaccine research and development (R&D) to support the prevention and control of seasonal and pandemic influenza. The committee's findings address four dimensions of vaccine R&D: (1) basic and translational science, (2) clinical science, (3) manufacturing science, and (4) regulatory science.

Contents:

Intro

FrontMatter

Reviewers

National Academy of Medicine: Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response Series

Acknowledgments

Preface

Contents

Boxes and Figures

Acronyms and Abbreviations

Summary

1 Introduction

2 Basic and Translational Science

3 Clinical Science

4 Manufacturing Science

5 Regulatory Science

6 A Blueprint for Action

Appendix A: Committee Biographies

Appendix B: Disclosure of Unavoidable Conflict of Interest

Appendix C: Staff and Consultant Biographies

Appendix D: Public Meeting Agendas.

Notes:

Description based on publisher supplied metadata and other sources.

Other Format:

Print version: Medicine, National Academy of Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response

ISBN:

9780309087858

0309087856

9780309087827

0309087821

OCLC:

1296425995